ICD-10-CM 2020 Search includes the entire 2020 code set for diagnostic coding in an easily searched always accessible web based platform.

Displaying 10401 - 10500 of 14364
Title
T43.91XA Poisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter
T43.92XA Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
T43.93XA Poisoning by unspecified psychotropic drug, assault, initial encounter
T43.94XA Poisoning by unspecified psychotropic drug, undetermined, initial encounter
T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
T43.96XA Underdosing of unspecified psychotropic drug, initial encounter
T44.0X1A Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter
T44.0X2A Poisoning by anticholinesterase agents, intentional self-harm, initial encounter
T44.0X3A Poisoning by anticholinesterase agents, assault, initial encounter
T44.0X4A Poisoning by anticholinesterase agents, undetermined, initial encounter
T44.0X5A Adverse effect of anticholinesterase agents, initial encounter
T44.0X6A Underdosing of anticholinesterase agents, initial encounter
T44.1X1A Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter
T44.1X2A Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter
T44.1X3A Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter
T44.1X4A Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter
T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T44.1X6A Underdosing of other parasympathomimetics [cholinergics], initial encounter
T44.2X1A Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
T44.2X2A Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
T44.2X3A Poisoning by ganglionic blocking drugs, assault, initial encounter
T44.2X4A Poisoning by ganglionic blocking drugs, undetermined, initial encounter
T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter
T44.2X6A Underdosing of ganglionic blocking drugs, initial encounter
T44.3X1A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter
T44.3X2A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter
T44.3X3A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter
T44.3X4A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.3X6A Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.4X1A Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
T44.4X2A Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
T44.4X3A Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
T44.4X4A Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T44.4X6A Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter
T44.5X1A Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter
T44.5X2A Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter
T44.5X3A Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter
T44.5X4A Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter
T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
T44.5X6A Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter
T44.6X1A Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter
T44.6X2A Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter
T44.6X3A Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter
T44.6X4A Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter
T44.6X5A Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
T44.6X6A Underdosing of alpha-adrenoreceptor antagonists, initial encounter
T44.7X1A Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter
T44.7X2A Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter
T44.7X3A Poisoning by beta-adrenoreceptor antagonists, assault, initial encounter
T44.7X4A Poisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter
T44.7X5A Adverse effect of beta-adrenoreceptor antagonists, initial encounter
T44.7X6A Underdosing of beta-adrenoreceptor antagonists, initial encounter
T44.8X1A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter
T44.8X2A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter
T44.8X3A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter
T44.8X4A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter
T44.8X5A Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.8X6A Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.901A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
T44.902A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
T44.903A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter
T44.904A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter
T44.905A Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44.906A Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44.991A Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
T44.992A Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
T44.993A Poisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter
T44.994A Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter
T44.995A Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
T44.996A Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter
T45.0X1A Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T45.0X2A Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T45.0X3A Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
T45.0X4A Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
T45.0X6A Underdosing of antiallergic and antiemetic drugs, initial encounter
T45.1X1A Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
T45.1X2A Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
T45.1X3A Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
T45.1X4A Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X6A Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
T45.2X1A Poisoning by vitamins, accidental (unintentional), initial encounter
T45.2X2A Poisoning by vitamins, intentional self-harm, initial encounter
T45.2X3A Poisoning by vitamins, assault, initial encounter
T45.2X4A Poisoning by vitamins, undetermined, initial encounter
T45.2X5A Adverse effect of vitamins, initial encounter
T45.2X6A Underdosing of vitamins, initial encounter
T45.3X1A Poisoning by enzymes, accidental (unintentional), initial encounter
T45.3X2A Poisoning by enzymes, intentional self-harm, initial encounter
T45.3X3A Poisoning by enzymes, assault, initial encounter
T45.3X4A Poisoning by enzymes, undetermined, initial encounter
T45.3X5A Adverse effect of enzymes, initial encounter
T45.3X6A Underdosing of enzymes, initial encounter
T45.4X1A Poisoning by iron and its compounds, accidental (unintentional), initial encounter
T45.4X2A Poisoning by iron and its compounds, intentional self-harm, initial encounter
T45.4X3A Poisoning by iron and its compounds, assault, initial encounter
T45.4X4A Poisoning by iron and its compounds, undetermined, initial encounter